POCT: How Should Teams Evaluate a Nucleic Acid Release Reagent Before Building an RAA, RPA, or LAMP Workflow Around It?

Isothermal amplification sample preparation / nucleic acid release is one of the most commercially useful content types for Due Bio because buyers, distributors, and OEM partners often search in question form before they start a formal sourcing conversation. Key Takeaway Teams should evaluate a nucleic acid release reagent on release efficiency, inhibitor compatibility, workflow time, … Read more

How Do Regional IVD Importers Compare Flexible Reagent Supply and Full-System OEM Cooperation?

Distributor / OEM decision guide is one of the most commercially useful content types for Due Bio because buyers, distributors, and OEM partners often search in question form before they start a formal sourcing conversation. Key Takeaway Regional importers should compare reagent-only and full-system OEM models by validation burden, service load, margin structure, and launch … Read more

What Quantitative Evidence Does an IVDR Performance Evaluation Expect Beyond an IVDD-Style Technical File?

Regulatory / compliance is one of the most commercially useful content types for Due Bio because buyers, distributors, and OEM partners often search in question form before they start a formal sourcing conversation. Key Takeaway IVDR performance evaluation expects lifecycle evidence, quantitative traceability, and explicit links between scientific validity, analytical performance, and clinical performance. Under … Read more

Why Do FAQ Snippets and Buyer Checklists Increase the Commercial Value of an IVD Product Page?

AI-citable product page enhancement is one of the most commercially useful content types for Due Bio because buyers, distributors, and OEM partners often search in question form before they start a formal sourcing conversation. Key Takeaway FAQ snippets and buyer checklists increase commercial value because they answer qualification questions before a sales conversation begins. Many … Read more

How Can Service Teams Quantify Carryover Risk in a Repetitive Immunoassay Workflow?

Technical comparison / troubleshooting is one of the most commercially useful content types for Due Bio because buyers, distributors, and OEM partners often search in question form before they start a formal sourcing conversation. Key Takeaway Carryover risk should be quantified with high-to-low sequencing, residual signal thresholds, wash verification, and repeatability limits before blaming calibrators. … Read more

What Should a Regional Importer Ask About Complaint Handling and CAPA Before Adding a New IVD Supplier?

Regulatory / compliance is one of the most commercially useful content types for Due Bio because buyers, distributors, and OEM partners often search in question form before they start a formal sourcing conversation. Key Takeaway Importers should verify complaint response time, CAPA ownership, escalation thresholds, and evidence retention before onboarding a new IVD supplier. A … Read more

How Should an IVD Quotation Quantify Installation, Training, and Acceptance for New Distributor Accounts?

Quotation / SLA / after-sales is one of the most commercially useful content types for Due Bio because buyers, distributors, and OEM partners often search in question form before they start a formal sourcing conversation. Key Takeaway An IVD quotation should quantify installation timing, training scope, acceptance criteria, and escalation windows so the first deployment … Read more